文献速递慢性肾脏病肾血管病与高血压

CKD孕妇重叠子痫前期的诊断指标

Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD.
PubMed 文献 · Kidney Int Rep · 2019-03-26

本研究在60例CKD孕妇中量化肾素-血管紧张素系统、内皮糖萼、补体激活及肾小管损伤相关血浆和尿液生物标志物,发现血浆透明质烷和VCAM可区分重叠子痫前期,且与胎盘生长因子相关。

要点

  • 血浆透明质烷和VCAM有助于区分CKD孕妇是否重叠子痫前期。
  • 两者与胎盘生长因子浓度相关,提示内皮功能障碍参与病理生理。
  • 肾素-血管紧张素系统标志物诊断价值受慢性高血压等因素影响。

核心结论

  • 内皮功能障碍可能参与重叠子痫前期的病理生理,血浆透明质烷和VCAM被假设具有诊断作用。

研究设计与样本

  • 研究纳入60例CKD孕妇(15例诊断重叠子痫前期、45例未发生)、18例子痫前期孕妇和20例正常妊娠孕妇,量化多类血浆和尿液生物标志物。

主要发现

  • CKD重叠子痫前期组血浆透明质烷为67.5 ng/ml,未发生组为27.5 ng/ml(P=0.0017,ROC曲线下面积0.80)。
  • CKD重叠子痫前期组血浆VCAM为1132 ng/ml,未发生组为659 ng/ml(P<0.0001,ROC曲线下面积0.86)。
  • 透明质烷和VCAM均与胎盘生长因子浓度相关。
  • 调整慢性高血压、降压药使用和黑人种族后,肾素-血管紧张素系统标志物的诊断区分度降低。
  • 其他标志物对重叠子痫前期的诊断区分度有限或无。

临床怎么用

  • 可考虑检测血浆透明质烷和VCAM辅助鉴别CKD孕妇是否重叠子痫前期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Diagnosis of superimposed preeclampsia in women with chronic kidney disease (CKD) is complicated by the presence of hypertension and proteinuria due to renal disease. The aims of this study were to determine mechanistic links between superimposed preeclampsia and renin-angiotensin system activation, endothelial pathology, complement dysfunction, and tubular injury, and to explore the role of diagnostic indicators of superimposed preeclampsia. METHODS: Plasma and urinary biomarkers derived from the renin-angiotensin system (active renin, angiotensinogen), endothelial glycocalyx (hyaluronan, intercellular adhesion molecule, vascular cell adhesion molecule [VCAM], P-selectin, E-selectin), complement activation (C3a, C5a, complement factor H, C5b-9), and tubular injury (kidney injury molecule-1, urinary lipocalin-2) were quantified in 60 pregnant women with CKD including 15 women at the time of superimposed preeclampsia diagnosis and 45 women who did not develop superimposed preeclampsia, 18 women with preeclampsia, and 20 normal pregnancies. Correlation with placental growth factor was assessed. RESULTS: Plasma concentrations of hyaluronan (67.5 ng/ml vs. 27.5 ng/ml, P = 0.0017, receiver operating characteristic area 0.80) and VCAM (1132 ng/ml vs. 659 ng/ml, P < 0.0001, receiver operating characteristic area 0.86) distinguished women with CKD and superimposed preeclampsia from those without superimposed preeclampsia, and correlated with placental growth factor concentration. The diagnostic discrimination of markers of the renin-angiotensin system was reduced by adjustment for chronic hypertension, antihypertensive drug use, and black ethnicity. Other markers offered limited or no diagnostic discrimination for superimposed preeclampsia. CONCLUSION: This study suggests that endothelial dysfunction contributes to the pathophysiology of superimposed preeclampsia and a diagnostic role for plasma hyaluronan and VCAM is hypothesized.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Wiles K, Bramham K, Seed PT, et al. Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD. Kidney Int Rep. 2019. PMID: 31194119. doi:10.1016/j.ekir.2019.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。